Drugs / Lavior Diabetic Wound Gel
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT05607979 Comparator | Dec 2022 → May 2024 | ulcer of lower limbs | Lavior Pharma Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lavior Diabetic Wound Gel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05607979 ↗ |
| Route | Topical | “Daily application of hydrogel treatment for 60 days.” NCT05607979 ↗ |